APA (7th ed.) Citation

Y, H., W, H., D, L., F, L., W, H., M, C., . . . H, D. (2026). Reassessing the efficacy and safety of trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia: A retrospective study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 45(5), 1247. https://doi.org/10.1007/s10096-026-05414-7

Chicago Style (17th ed.) Citation

Y, Hu, et al. "Reassessing the Efficacy and Safety of Trimethoprim-sulfamethoxazole for Pneumocystis Jirovecii Pneumonia: A Retrospective Study." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 45, no. 5 (2026): 1247. https://doi.org/10.1007/s10096-026-05414-7.

MLA (9th ed.) Citation

Y, Hu, et al. "Reassessing the Efficacy and Safety of Trimethoprim-sulfamethoxazole for Pneumocystis Jirovecii Pneumonia: A Retrospective Study." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 45, no. 5, 2026, p. 1247, https://doi.org/10.1007/s10096-026-05414-7.